Skip to content
Disclosery

B Group, Inc.

Follow

13F filer, CIK 2043476, DALLAS, TX

B Group, Inc. reported $134,887,410 across 20 holdings for the quarter ended 2026-03-31, in a 13F-HR filed 2026-05-15. Its ten largest share positions make up 81.07% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001420506-26-001023

Period
2026-03-31
Reported value
$135M
Holdings
20
Top 10 weight
81.07%
New
5
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
PALIadded+6,914,285$12.1M
ADMAadded+750,000$6.76M
NRXPnew+3,000,000$6.39M
DRUGnew+67,500$4.93M
GPCRadded+37,500$1.81M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
APGEreduced-12,500-$1.05M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2026

Share positions as resolved from 13F-HR 0001420506-26-001023, largest first. % of portfolio is the value over $134,887,410, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ADMAADMA BIOLOGICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 2,287,542 shares; 2025Q1: 2,317,542 shares; 2025Q2: 2,317,542 shares; 2025Q3: 2,412,542 shares; 2025Q4: 2,457,542 shares; 2026Q1: 3,207,542 shares 3,207,542$28.9M21.43%+750,000Timeline
PALIPALISADE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,500,000 shares; 2026Q1: 11,414,285 shares 11,414,285$20M14.81%+6,914,285Timeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 19,000 shares; 2025Q2: 35,000 shares; 2025Q3: 31,500 shares; 2025Q4: 33,237 shares; 2026Q1: 33,237 shares 33,237$10.7M7.94%0Timeline
CLLSCELLECTIS S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 3,081,501 shares; 2025Q1: 3,256,501 shares; 2025Q2: 3,256,501 shares; 2025Q3: 3,281,501 shares; 2025Q4: 3,281,501 shares; 2026Q1: 3,281,501 shares 3,281,501$10.4M7.71%0Timeline
ZLABZAI LAB LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 400,000 shares; 2025Q1: 400,000 shares; 2025Q2: 400,000 shares; 2025Q3: 400,000 shares; 2025Q4: 400,000 shares; 2026Q1: 450,646 shares 450,646$8.48M6.28%+50,646Timeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 965,556 shares; 2025Q1: 1,255,556 shares; 2025Q2: 1,800,556 shares; 2025Q3: 1,800,556 shares; 2025Q4: 1,800,556 shares; 2026Q1: 1,800,556 shares 1,800,556$8.05M5.97%0Timeline
NRXPNRX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,000,000 shares 3,000,000$6.39M4.74%newTimeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 90,000 shares; 2026Q1: 127,500 shares 127,500$6.15M4.56%+37,500Timeline
IOVAIOVANCE BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 992,000 shares; 2025Q1: 1,500,000 shares; 2025Q2: 1,500,000 shares; 2025Q3: 1,500,000 shares; 2025Q4: 1,500,000 shares; 2026Q1: 1,500,000 shares 1,500,000$5.26M3.9%0Timeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 50,000 shares; 2025Q1: 70,000 shares; 2025Q2: 80,000 shares; 2025Q3: 100,000 shares; 2025Q4: 100,000 shares; 2026Q1: 100,000 shares 100,000$5.04M3.74%0Timeline
DRUGBRIGHT MINDS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 67,500 shares 67,500$4.93M3.65%newTimeline
ASMBASSEMBLY BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 50,651 shares; 2025Q1: 200,000 shares; 2025Q2: 189,350 shares; 2025Q3: 175,706 shares; 2025Q4: 175,706 shares; 2026Q1: 175,706 shares 175,706$4.88M3.61%0Timeline
AURAAURA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 472,576 shares; 2025Q1: 472,576 shares; 2025Q2: 572,576 shares; 2025Q3: 572,576 shares; 2025Q4: 572,576 shares; 2026Q1: 597,576 shares 597,576$4M2.96%+25,000Timeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 20,000 shares; 2025Q1: 58,215 shares; 2025Q2: 75,000 shares; 2025Q3: 75,000 shares; 2025Q4: 75,000 shares; 2026Q1: 75,000 shares 75,000$3.68M2.73%0Timeline
SGHTSIGHT SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 629,370 shares; 2025Q1: 833,600 shares; 2025Q2: 930,000 shares; 2025Q3: 930,000 shares; 2025Q4: 920,000 shares; 2026Q1: 970,000 shares 970,000$3.66M2.71%+50,000Timeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 7,596 shares; 2025Q1: 47,500 shares; 2025Q2: 110,000 shares; 2025Q3: 135,000 shares; 2025Q4: 135,000 shares; 2026Q1: 135,000 shares 135,000$2.83M2.1%0Timeline
APGEAPOGEE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 15,000 shares; 2025Q1: 30,000 shares; 2025Q2: 35,000 shares; 2025Q3: 35,000 shares; 2025Q4: 20,000 shares; 2026Q1: 7,500 shares 7,500$631K0.47%-12,500Timeline
FHTXFOGHORN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 102,000 shares 102,000$488K0.36%newTimeline
SLNOSOLENO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 7,500 shares 7,500$251K0.19%newTimeline
REPLREPLIMUNE GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 26,000 shares 26,000$199K0.15%newTimeline

Sold out in Q1 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
REPLREPLIMUNE GROUP INC50,000$486Kcall

How Q1 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001420506-26-001023 base2026-05-15acceptance time not in the bulk data set